Possible involvement of gelatinase A (MMP2) and gelatinase B (MMP9) in toxic epidermal necrolysis or Stevens-Johnson syndrome

Archives of Dermatological Research

Volumn 296, Issue 5, 2004, Pages 220-225

  Gaultier, F ^a   Ejeil, A L ^a   Igondjo Tchen, S ^a   Dohan, D ^a,b   Dridi, S M ^a   Maman, L ^a   Wierzba, C B ^a   Stania, D ^a   Pellat, B ^a   Lafont, A ^b   Godeau, G ^a   Gogly, B ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c Hopital Albert Chenevier   (France)

Author keywords

Blister fluid; Gelatinase A (MMP2); Gelatinase B (MMP9); Organ culture; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

GELATINASE A; GELATINASE B;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPLANT; HUMAN; HUMAN TISSUE; IMMUNODETECTION; PRIORITY JOURNAL; SKIN CULTURE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 8644275384     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-004-0506-z     Document Type: Article

References (29)

1. Bastuji-Garin S, Rzany B, Stern RS, et al (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92-96
2. Beranger JY, Godeau G, Frances C, Robert L, Hornebeck W (1994) Presence of gelatinase A and metalloelastase type protease at the plasma membrane of human skin fibroblasts. Influence of cytokines and growth factors on cell-associated metalloendopeptidase levels. Cell Biol Int 18:715-722
3. Birkedal-Hansen H (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735
4. Bombal C, Roujeau JC, Kuentz M, Revuz J, Touraine R (1983) Hematologic anomalies in Lyell's syndrome. Study of 26 cases. Ann Dermatol Venereol 110:113-119
5. Cuello C, Wakefield D, Di Girolamo N (2002) Neutrophil accumulation correlates with type IV collagenase/gelatinase activity in endotoxin induced uveitis. Br J Ophthalmol 86:290-295
6. Finlay GA, O'Driscoll LR, Russell KJ, et al (1997) Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156:240-247
7. Gearing AJ, Beckett P, Christodoulou M, et al (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370:555-557
8. Katz AB, Taichman LB (1999) A partial catalog of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol 112:818-821
9. Kobayashi T, Hattori S, Nagai Y, Tajima S, Nishikawa T (1998) Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatology 197:1-5
10. Munaut C, Noel A, Weidle UH, Krell HW, Foidart JM (1995) Modulation of the expression of interstitial and type-IV collagenases in coculture of HT1080 fibrosarcoma cells and fibroblasts. Invasion Metastasis 15:169-178
11. Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160
12. Oikarinen A, Kylmaniemi M, Autio-Harmainen H, Autio P, Salo T (1993) Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol 101:205-210
13. Paquet P, Pierard GE (1997) Erythema multiforme and toxic epidermal necrolysis: a comparative study. Am J Dermatopathol 19:127-132
14. Paquet P, Nikkels A, Arrese JE, Vanderkelen A, Pierard GE (1994) Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 130:605-608
15. Paquet P, Nusgens BV, Pierard GE, et al (1998) Gelatinases in drug-induced toxic epidermal necrolysis. Eur J Clin Invest 28:528-532
16. Ratzinger G, Stoitzner P, Ebner S, et al (2002) Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol 168:4361-4371
17. Revuz J, Penso D, Roujeau JC, et al (1987) Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol 123:1160-1165
18. Roujeau JC (1997) Stevens-Johnson syndrome and toxic epidermal necrosis are severity variants of the same disease which differs from erythema multiforme. J Dermatol 24:726-729
19. Roujeau JC, Moritz S, Guillaume JC, et al (1985) Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis. Arch Dermatol Res 277:24-27
20. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP (1990) Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985. Arch Dermatol 126:37-42
21. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H (1991) Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266:11436-11441
22. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF (1991) Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 127:839-842
23. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG (1991) Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266:7870-7875
24. Serra J (1987) Morphological optics. J Microsc 145 (Pt 1):1-22
25. Varani J (1998) Preservation of human skin structure and function in organ culture (review). Histol Histopathol 13:775-783
26. Viard I, Wehrli P, Bullani R, et al (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490-493
27. Villada G, Roujeau JC, Cordonnier C, et al (1990) Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. J Am Acad Dermatol 23(5 Pt 1):870-875
28. Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman HK (1993) Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J Cell Physiol 157:644-649
29. Young PK, Grinnell F (1994) Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol 103:660-664